A variety of acetylcholinesterase inhibitors (AChEIs), including tacrine, donepezil, galantamine, and rivastigmine, have been used to treat cognitive impairment and memory loss in patients with mild to moderate AD [17,18] (Figure 1). The gene discussed is ACHE; the disease is Alzheimer disease.